European Heart Journal

Article	Citations
SARS-CoV2 infection: functional and morphological cardiopulmonary changes in elite handball players	8254
Long-term follow-up of early leaflet thrombosis after transcatheter aortic valve replacement	3920
Associations between changing patterns of ST-T waves morphologies in rest electrocardiography and cardiovascular risk in an asymptomatic low risk population: a report from Ansan-Ansung cohort study	3410
Lipid testing trends before and after hospitalization for myocardial infarction among adults in the U.S., 2008–2019	2054
Prognostic value of cardiac magnetic resonance in elderly patients soon after ST-segment elevation myocardial infarction	1875
Influence of diabetes, heart failure, and NT-proBNP on cardiovascular outcomes in patients with atrial fibrillation – insights from a cohort study of 7,412 patients with extended follow-up	1559
The role of bystander-initiated basic life support in exercise-related sudden cardiac arrest: a systematic review	1459
Comparison of valve durability among different transcatheter and surgical aortic valve prostheses: a network meta-analysis	1258
Left main coronary artery dimension and variation in Thai population	1054
Protective effects of dapagliflozin on vascular remodeling in the carotid artery following balloon injury – potential role of angiotensin and purinergic signaling	964
Leukocyte telomerase concentration is inversely associated with central wave reflection in patients with hypertension	855
The bimodal rise and fall acute coronary syndromes curves paralleling COVID-19 outbreaks	719
Novel insights into the management of German patients with very high cardiovascular risk eligible for PCSK9 inhibitor treatment: baseline characteristics from the PERI-DYS study	674
Clinical characteristics and natural history of pre-adolescent non-syndromic hypertrophic cardiomyopathy	662
Cardiac reparative therapy with adipose graft transposition procedure (AGTP) improves electrophysiological remodeling of chronic myocardial infarction	650
The impact of diabetes mellitus on carotid atherosclerosis and arterial stiffness; results from the Corinthia study	642
Percutaneous coronary intervention in patients with peripheral artery disease and adverse cardiovascular adverse event and bleeding	620
Percutaneous bioprosthetic aortic valve durability: results a single center after ten years of follow-up ago	525
Human pericardial fluid exosomes regulate macrophage immunophenotype: new prospective for cardiovascular myocardium-epicardium crosstalk in coronary artery disease	522
Speckle tracking-derived left atrial stiffness predicts adverse events after successful electrical cardioversion	464
Initial combination therapy for hypertension in patients of African ancestry: a systematic review and meta-analysis	461
Cohort of patients with hypertrophic cardiomyopathy and alpha tropomyosin 1 variants followed up at a national reference center	443
Coronary perforations and its clinical impact during CTO recanalization: a 2054 patients pooled analysis from the Latin American (LATAM) CTO registry	375
Impact of left heart disease risk factors on risk stratification and treatment response in pulmonary arterial hypertension	360
Staging cardiac damage in aortic valve disease: one size fits all?	336

Gender bias in ACS management	311
Concomitant real-time measurement and correlation of contact force to baseline local impedance and local impedance drops in RF ablation of left and right atrial procedures	304
Impact of catheter ablation on functional tricuspid regurgitation in patients with atrial fibrillation	299
Blood pressure response during treadmill exercise testing and the risk for future cardiovascular events and new-onset hypertension	277
TAPSE or right-to-lleft ventricle diameter ratio at echocardiography to predict death in patients with acute pulmonary embolism: a meta-analysis	269
The effect of prolonged Intraaortic ballon pump (IABP) support on right ventricular function in end-stage heart failure	262
Comparison of mortality prediction scores in elderly patients with ICD for heart failure with reduced ejection fraction	219
Pericardiocentesis over 3 years at a tertiary referral Australian hospital	218
Left atrial strain evaluation and prognostic value in constrictive pericarditis patients undergoing pericardiectomy	209
Exploring the cross-talk between liver and vessels through increased morning blood pressure in hypertension	203
Correction to: 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary sy	202
Characteristics of warfarin underprescription in older adults with atrial fibrillation	200
Incidentally induced atrial fibrillation during programmed electrical stimulation in patients with depressed left ventricular systolic function after an acute myocardial infarction: a CARISMA substudy	199
Correlation of Seattle Angina Questionnaire score and post-procedural outcomes in patients undergoing multi-vessel coronary intervention	197
Wild-type transthyretin cardiac amyloidosis: the need for a comprehensive geriatric assessment beyond age	195
Induction of RAGE-NFkB signalling axis enhances SHP-2 tyrosine phosphatase expression resulting in deviant activation of diabetic monocytes	185
Dynamic optimization of CRT pacing using a novel algorithm improves survival in a real-world cohort of patients	176
Identification of potential therapeutic targets for coronary artery disease based on protein array and Mendelian Randomization analysis	175
Impact of left atrial strain assessed with feature-tracking computed tomography on long-term mortality after transcatheter aortic valve implantation	171
Percutaneous transluminal angioplasty associated with a comparable risk of mortality in old patients with severe lower extremities arterial disease	170
Leadless pacemaker implant in the elderly: a safe and feasible solution	168
Validity and utility of the questionnaire-based FRAIL scale in elderly patients with heart failure: findings from the FRAGILE-HF	165
Use of sirolimus-coated balloon in de novo small vessel coronary lesions; Long-term follow-up from a single centre registry	159
Adherence to guidelines of diagnostic and therapeutic practices for suspected infections of cardiac implantable electronic devices	158
Two types of humoral response in acute myocardial infraction	153
Protective effects of different types of bariatric surgeries on myocardial ischemia-reperfusion injury in non-obese non-diabetic rats	149
Long-term outcomes in patients with left bundle branch block after transcatheter aortic valve replacement	144
Pregnancy in women with hypertrophic cardiomyopathy: observational data from the tertiary referral center registry	142
Myocardial performance is impaired in cardiac amyloidosis: role of myocardial work-derived parameter in differential diagnosis with phenocopies and prognostic implications	142
Interaction of inherited genetic variants in the NLRP3 inflammasome/IL-6 pathway with acquired clonal hematopoiesis to modulate mortality risk in patients with HFrEF	142
Stroke volume but not ejection fraction predicts prognosis in acute heart failure	140
Simulating atrial fibrillation patterns and screening strategies using virtual patient-level models	139
Real-world performance of a fully automatic antitachycardia pacing algorithm	138
Prognosis of diastolic dysfunction in patients with preserved LVEF. Value of left atrial strain	137
Atrial fibrillation organisation correlates with ventricular response regularity in patients with persistent atrial fibrillation	134
Subclavian versus axillary vein puncture for implantation of cardiac electronic devices. A meta-analysis	131
Impact of a 12-week supervised exercise program on weight loss trajectory, daily physical activity levels and sedentary behaviors after bariatric surgery	131
Release velocity improvement with a new metronome-guided chest compression protocol: preliminary results of the RITMICO study	131
Heart failure with reduced ejection fraction: predicting exercise intolerance with echocardiography	130
Effect of antimicrobial therapy on the embolic events in patients with infective endocarditis	129
A variant noncoding region regulates Prrx1 and predisposes to atrial arrhythmias	127
Less dementia in patients with newly diagnosed atrial fibrillation adhering with a clustering of healthy lifestyle behaviours: a nationwide population-based cohort study	126
Association between plasma desmosine, a marker of elastin degradation, and total atherosclerotic burden measured by whole body magnetic resonance angiography	126
Absence of exercise capacity improvement after in-hospital short-term cardiac rehabilitation is associated with long-term clinical outcome in heart failure patients	125
Safety and efficacy of cerebral embolic protection devices in transcatheter aortic valve implantation: a meta-analysis	123
Global burden of metabolic diseases: data from Global Burden of Disease 2000-2019. A cosortium of metabolic disease	122
Trends in infective endocarditis mortality in the United Kingdom and EU 15+ countries between 1990–2019: an analysis of the Global Burden of Diseases database	120
Protective effects of renal denervation based on MRI assessment of the brain in patients with resistant hypertension	117
Corrigendum to: Backup natural pacemaker found in the heart	117
Predictive value of the left ventricular function in coronary artery disease: should we tailor risk-stratification for men and women?	116

Elevated markers of liver function are associated with poorer outcomes in HFREF: an analysis of DAPA-HF	116
Secondary prevention of cerebrovascular events in patients with “asymptomatic” atherosclerotic stenosis of the vertebral arteries	115
Cumulative prognostic effect of diabetes and myocardial injury in patients attended in the emergency room	114
Prediction of early left ventricular recovery and adverse remodelling in patients with acute myocardial infarction: the role of non-invasive myocardial work evaluation	111
Eisenmenger syndrome: is it the same entity in adulthood and pediatric age?	111
Feasibility of remote support for electrophysiological ablation procedures during CoVid-19 pandemics	111
The impact of non-pharmacological therapies on cardiovascular outcomes in patients with refractory angina: a systematic review and meta-analysis of randomized controlled trials	110
Peripheral vascular involvement in transthyretin cardiac amyloidosis. A comparative analysis with AL amyloidosis	110
Allied health professional-physician collaboration to enhance guideline-directed medical therapy of heart failure: expanding therapeutic opportunities	109
Effect of LPA gene on CAD risk among diabetic patients	109
Association of liver dysfunction with outcomes after percutaneous coronary intervention - a systematic review and meta-analysis	108
Impact of COVID-19 pandemics on the incidence and mortality in Takotsubo syndrome: a report from Swedish Coronary Angiography and Angioplasty Registry	107
Beta-blockers after STEMI: prognostic impact and predictors of adherence, results from the real-world FAST-STEMI registry	107
The expression of selected microRNAs enables identification of patients with functional atrial tricuspid regurgitation. New insights into TR pathophysiology	107
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study	107
Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis	106
Artificial intelligence-assisted examination of cardiac health status through electrocardiogram	106
Acute infections and inflammatory biomarkers in patients with acute pulmonary embolism	106
Clinical profile and incidence of 36-month cardiovascular events in patients with MINOCA: a regional registry of 126 patients in a tertiary cardiology hospital	105
Pulmonary artery aneurysm in pulmonary arterial hypertension associated with congenital heart disease	103
Evaluating the safety and long-term efficacy of triple vasodilator therapy for pulmonary arterial hypertension associated with congenital heart disease	103
Associations of maternal exposure to multiple plasma metals with the risk of fetal congenital heart defects: a prospective nested case-control study	103
Microtransesophageal echocardiographic guidance of patent foramen ovale percutaneous closure	102
Amiodarone and the risk for pulmonary fibrosis. A Danish nationwide study	102
Cumulative accelerometer-based sedentary time from childhood through young adulthood with progressive left ventricular remodelling in British youth: a 13-year longitudinal study	102
Coronary rotational atherectomy in patients with severe aortic stenosis	101
Outcomes of chronic total occlussion recanalization in patients with prior bypass-surgery: an updated systematic review and meta-analysis of real world registries	100
Estimation of antihypertensive effect after initiating continuous positive airway pressure treatment in Japanese patients with sleep disordered breathing	100
Reporting quality of randomized controlled trials of percutaneous patent foramen ovale closure for the treatment of migraine based on the CONSORT statement	100
Early lowering of LDL-C is a more cost-effective strategy than lowering LDL-C later in life: a cost-effectiveness analysis using Mendelian Randomisation	100
Reducing the burden of inconclusive smart-device single-lead ECG tracings via a novel atificial intelligence algorithm	99
Efficacy of intravascular lithotripsy (IVL) in coronary stenosis with severe calcification: a systematic review and meta-analysis of 38 studies	99
Feasibility and efficacy of a novel 6 french sheathless guiding catheter equipped with peel-off type external dilator for PCI with distal radial approach - a Japanese multicenter study	99
Moderate mixed aortic valve disease -evaluation, treatment and prognosis of patients referred to heart valve center	98
Cardiovascular safety of non-steroidal anti-inflammatory drug use for gout: A Danish nationwide case-crossover study	98
Associated factors and clinical implications of dynamic changes in late gadolinium enhancement after acute myocarditis	97
Cardiac troponin T and I are differentially associated with myocardial fibrosis assessed by cardiac magnetic resonance imaging	97
Myocardial performance index improves prediction of major adverse cardiovascular events and heart failure in type 1 and type 2 diabetes without known heart disease: Thousand&1 and Thousand&2 s	96
Machine learning using cardiovascular magnetic resonance to predict cardiovascular events in patients with acute myocarditis	95
Left ventricular early diastolic strain rate and cardiovascular outcome in patients with left ventricular non-compaction phenotype	94
Spin-lock based magnetic field sensing: a non-invasive MRI method for spatially resolved imaging of cardiac conduction?	94
Agreement between two independent raters in identifying exercise oscillatory ventilation in patients with heart failure	93
Management of hospital resources for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) - an approach to deescalate ?	93
Evaluating the effect of the antiPCSK9 vaccine on systemic inflammation and oxidative stress in CFA-challenged albino mice	93
MINOCA due to vasospasm compared to other mechanisms: patients characteristics, evolution and prognosis	93
Age differences in the association between arterial velocity pulse index and muscle sympathetic nerve activity in hypertensive patients	92
Contrast-induced nephropathy after staged balloon pulmonary angioplasty: lower risk compared with left-sided cardiac procedures	91
Emotional and cardiovascular health: the impact of depression on cardiac autonomic activity	91
Abnormal left-sided blood volume, wall shear stress & energy loss in patients with repaired Tetralogy of Fallot identified by 4D flow MRI	89
Coronary lesions suggestive of kawasaki disease in young patients presenting with acute myocardial infarction	86
His bundle pacing: safety, performance, and clinical outcomes in a single centre experience	86
Genome-wide association study of atrial fibrillation in 114,539 Finnish individuals reveals novel locus associated with cardiac remodelling	86
Beta-blocker could show the prognostic impact in heart failure patients even on the regular hemodialysis	85
Association of Body mass index and clinical outcomes in patient with coronary artery disease undergoing percutaneous coronary intervention	84
Effect of risk enhancers versus technical aspects of high thrombotic risk criteria on adverse clinical events after PCI: insights from 2020 ESC NSTE-ACS Guidelines	84
Vericiguat: a QTc interval study in patients with coronary artery disease	82
Endocardial pacing compared to epicardial left ventricle pacing and right ventricle pacing: a single center long term experience in a pediatric population	82
Uncontrolled diabetes predicts anxiety and depression in CAD patients	82
Hypolipidemia associated with inactivation of TM6SF2 is due to decreased VLDL-lipids secretion	81
Impact of cumulative burden of body mass index and waist circumference on risk of atrial fibrillation: an analysis of 3,700,000 participants who underwent 4-year consecutive annual health examination	81
Leuko-platelet index as an independent predictor of in-hospital events in patients with non-ST elevation acute coronary syndrome	81
Ventricular-arterial coupling changes as an early predictor of left ventricular remodelling in atrial fibrillation	80
An association of low-density lipoproteins and fibrinolysis in patients with severe aortic stenosis- valvular expression of fibrinolytic proteins	79
The impact of mitral regurgitation grade on exercise capacity following cardiac rehabilitation program after transcatheter aortic valve implantation	79
Outcomes of patients with high bleeding risks characteristics presenting with acute coronary syndrome undergoing percutaneous coronary intervention	79
Cardiac complications as a major predictor of in-hospital death in infective endocarditis using machine-learning algorithm analysis	79
Intricacies of aortic risk assessment studies: not a simple matter	78
Residual leaks after transcatheter left atrial appendage closure: why and how to assess it?	78
Leveraging global coronary flow assessments to inform revascularization benefit in chronic coronary disease: time to test total heart flow	77
The Antwerp score: is this the ‘new hope on the horizon’?	76
Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation	76
Reflections on Hypertrophic Cardiomyopathy	76
Pulmonary haemodynamics and pulmonary congestion: where are we now?	76
A newly designed glucagon-like peptide-1 receptor agonist reduces cardiovascular and renal events in high-risk type 2 diabetes	75
Female representation on editorial boards of the National Societies of Cardiology Journals of the European Society of Cardiology	74
New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies	73
Does transition through menopause affect cardiovascular disease risk factors? Results from a population-based cohort (CoLaus study)	73
Beyond reproductive health: the cardiovascular risks of endometriosis	73
A rare case of a dorsal mass caused by descending thoracic aortic dissection	73
Location and impact of the infarct-related artery in acute coronary syndrome: insight from the Swiss SPUM- ACS cohort	72

Meet the European Society of Cardiology Gold Medallists 2022	72
Ablation therapies for paroxysmal atrial fibrillation: a systematic review and patient-level network meta-analysis	72
Corrigendum to: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled	72
Outcomes of extracorporeal membrane oxygenation with or without left ventricular unloading devices in patients with non-myocardial infarction cardiogenic shock	72
New challenges in vascular biology and medicine: from unravelling the mechanisms of neointima formation to the prevention of amputations and of ischaemic stroke	71
Reduced 3D-left atrium ejection fraction predicts development of atrial fibrillation in patients with hypertrophic cardiomyopathy	71
Microvascular dysfunction and absolute coronary blood flow after percutaneous coronary intervention of a chronic total occlusion	71
Characteristics and long-term ablation outcomes of supraventricular arrhythmias in hypertrophic cardiomyopathy: a 10-year, single-center experience	71
Sequential left ventricular electro-mechanical changes in left bundle branch pacing vs right ventricular pacing a two-center study	71
Sympathetic nerve activity changes following acute exposures to electronic and tobacco cigarette smoking in humans	71
Figuring out complete left ventricular reverse remodeling in tachycardiomyopathy	71
Early diastolic strain rate and its associations with estimated glomerular filtration rate and albuminuria	70
Right ventricular free wall longitudinal strain (RVFWSL) a new outcome predictor in patients candiate for TAVI	70
Post-systolic shortening index by echocardiography evaluation of dyssynchrony in the non-dilated and hypertrophied left ventricle	70
ARNI effects in HFrEF. Risk reduction beyond LVEF	69
Heart failure therapy in new onset heart failure versus chronic heart failure: an analysis of 90,383 patients from the Swedish Heart Failure Registry (SwedeHF)	69
What is there to EAARN with a CRT implantation? Predictive factors of mortality or clinical deterioration in patients receiving cardiac resynchronization therapy based on pre-implant factors	69
Targeting Neurofibromin 2 (NF2) prevents endothelial dysfunction in obesity: a study in mice and humans	69
Differential efficacy and safety of oral anticoagulation in atrial fibrillation patients with or without comorbid vascular disease: insights from the GARFIELD-AF registry	69
Prognostic impact of echocardiographic derived precapillary wedge pressure and pulmonary vascular resistances in patients with heart failure	69
Early Intervention with Impedance-guided Heart Failure Management Improves Long-term Outcome: insights From the IMPEDANCE-HF Trial	69
Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction?	68
Sacubitril-valsartan activates pAMPK and reduces NLRP3, MyD88, cytokines/growth factors and DAMPs in doxorubicin-treated mice improving longitudinal strain and ejection fraction	67
Expression changes of circulating ACE2 regulating-microRNA profiles in patients with COVID-19 during hospitalisation	67
Real-time electrophysiological characterization of acute and chronic radiofrequency ablation lesions	67
Routine use of 3-dimensional zoom modality with 2-dimensional transesophageal echocardiography to decide the candidacy for transcatheter device closure of atrial septal defect	67
Progression, regression and redefining the treatment response – cardiac magnetic resonance with T1 and extracellular volume mapping in cardiac light-chain amyloidosis	67
Influence of lead extraction on tricuspid valve function	66
Epicardial adipose tissue volume and density is associated with cardiac dysfunction in asymptomatic people with type 2 diabetes	66
Morphology-Voltage-P-wave duration (MVP) score in prediction of incident atrial fibrillation in an elderly epidemiologic cohort	66
Influence of radiotherapy on cardiac implantable device lead parameters	66
Further prognostic stratification in patients with oscillatory ventilation with exercise: is there more to it than just ups and downs?	65
Various arrhythmia types and their day-by-day occurrence rates over a 14-day period using a P-wave sensitive ambulatory ECG monitored population	64
Acute and long-term success of left atrial anterior line and mitral isthmus line ablation in patients after mitral valve surgery	64
Mortality and predictors of death in women and men with congestive heart failure of different types of cardiomyopathies	64
Temporal trends in infection-related hospitalizations in patients with heart failure: a nationwide study from 1997 to 2017	63
Bipolar ablation of refractory ventricular arrhythmias using a novel dedicated adapter. A multicenter study	63
Ten year survival after an acute heart failure episode	63
Strategic management to optimize response to cardiac resynchronization therapy registry	63
Phenotyping of heart failure with preserved ejection faction using health electronic records and echocardiography	63
Variations in atrial fibrillation screening after ischemic stroke or transient ischemic attack in Sweden	63
Primary care screening and prevention of heart failure coordinated by cardiologist in rural areas	62
Results from a nationwide atrial fibrillation screening effort in Belgium	62
Real-world data from the use of ranolazine in patients with stable angina pectoris: the RANGER study	62
Combined cardiopulmonary test and exercise Doppler echocardiography in systemic sclerosis	61
Acute effects of COVID-19 vaccination on inflammatory, macrovasular and microvascular biomarkers	61
Ten years survival benefit of CABG or PCI based on individual prediction	61
Acute heart failure after non-cardiac surgery: incidence, phenotypes, determinants and outcomes	61
Efficacy of controlvit as a complementary strategy in reducing hospitalizations in patients with heart failure. Randomized clinical trial	61
COVID-19 vaccination in the pediatric age and risk for myocarditis	60
The COVID-19 pandemic and heart failure: lessons from GUIDE-HF	60
Application of the 2019 ESC/EAS dyslipidemia guidelines to a Mexican population: evaluating treatment targets for secondary prevention in clinical practice	60
Strengthening cardiovascular trials across Australia and New Zealand—the Alliance for Cardiovascular Trials (ANZACT) Network	60
Unmeasured confounding is always unnerving: cannabis and cardiovascular risk	60
NOAC in adult congenital heart disease patients: a single-center experience	60
Atherogenic lipoprotein profile associated with anthropometric indices of obesity and their association with cardiometabolic risk markers: a cross-sectional study in community	60
Why Y? The Y chromosome may serve a cardiovascular purpose after all	60
Obituary Joep Perk	59
Taking inspiration from birds to improve flow in prosthetic heart valves: an European Research Council granted project	59
Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century	59
Brugada syndrome: can polygenic risk scores help the clinician?	59
Additional value of 18fluorodeoxyglucose positron emission tomography/computed tomography combined with intracardiac echocardiography to detect lead vegetations	59
Hypernatremia and subclinical chronic kidney disease	59
Follow-up on new marker confirming the optimal status in the treatment of heart failure with reduced ejection fraction	58
Immortal Time Bias: the hidden confounder in assessing cardiosurgical treatment effects	58
The extended role of 24 h ambulatory blood pressure monitoring for reflex syncope	58
Risk of knowing too much: the tricky case of estimated glomerular filtration rate and treatment decisions in heart failure	58
One-shot thrombolysis for the management of acute ischaemic stroke	58
When two is not better than one: the amalgamation of atrial fibrillation and chronic obstructive pulmonary disease	58
Do we need new thresholds for surgical repair in patients with ascending thoracic aortic aneurysm disease?	58
Isolated early peak cardiac troponin for clinical decision-making after elective cardiac surgery: useless at best	57
Reconsidering safety and reducing barriers to MRI in patients with cardiac implantable electronic devices	57
A case of crowded heart: closing the door after the visitors	57
Stress echocardiography: the quest for risk stratification beyond myocardial ischaemia	57
High plasma levels of soluble LOX-1 portends poor survival in acute coronary syndromes beyond GRACE 2.0: a multicentre prospective cohort study	56
Doubly committed ventricular septal defect closure using an eccentric occluder via minimal incision in the anterior median sternum through the left parasternal third intercostal space	56
Impact of diabetes mellitus on long-term survival after transcatheter mitral valve edge-to-edge repair	56
Breathing danger: linking air pollution to cardiovascular disease and increased risk of abdominal aortic aneurysm	56
Validation of HAS-BELD scoring system and risk factors of bleeding with warfarin among non-valvular atrial fibrillation patients	56
Elevated serum xylitol levels and cardiovascular risk: an active component or an innocent bystander?	56
Behavioral economics strategies for promoting adherence to treatment in heart failure patients	55
Increased right amygdala activity during the hyper-acute phase of takotsubo syndrome	55
Dissecting the effect of genetic variants on atherosclerosis: integrating bulk and single-cell transcriptomics	55
Do health care physician need to risk their own lives? Time to change our own attitude towards recommended physical activity	55
Does gut microbiota affect atrial rhythm? Causalities and speculations	55
Diffusion tensor imaging to assess myocardial microstructure after infarction by magnetic resonance	55
Weekly journal scan: a hard RAFTing to improve long-term survival in heart failure with severely reduced ejection fraction	55
Impact of malignancy on outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General Long-Term Registry	54
Management and clinical outcome of patients with atrial fibrillation stratified by the 4S-AF scheme for structured characterization of atrial fibrillation: data from CODE-AF registry	54
Ischemic stroke in patients with congenital heart disease and atrial fibrillation	54
Therapeutic components of an automated digital counselling intervention for chronic heart failure	54
12-month post-trial follow-up of participants in the Australian arm of the second low-dose colchicine trial	54
Characterisation of metabolic phenotype in aortic stenosis: insights from a multi-parametric cardiac magnetic resonance study	54
The role of process mining tools in STEMI networks: where should we build a new primary PCI centre?	54
Disease trajectories following myocardial infarction: insights from process mining of 145 million hospitalisation episodes	54